Fig. 9From: Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseasesClinical-stage antibodies against AD target different microscopic steps in Aβ42 aggregation. From Linse et. al [272]Back to article page